Lorcaserin and Q-Nexa Before FDA


Uploaded on May 22, 2012 by Robotic Oncology

Dr. David Samadi, leading prostate cancer surgeon, says the FDA could approved these two new weight loss drugs as early as June 2012. While heart valve damage is a potential side effect, the benefits of weight loss could outweigh the risks for some patients. Neither drug promises significant weight loss, however, and are not a substitute for portion control, health diet, and exercise.

Prostate Cancer Surgeon Ny, Best Prostate Cancer Doctor, Prostate Treatments, Robotic Prostate Surgery, Dre Exam, Prostate Cancer Staging, Prostate Cancer Diagnosis, Best Prostate Cancer Cure, Prostate Removal And Sex, Obesity, Weight Loss Drugs, Lorcaserin, Qnexa, News & Events
Comments on Lorcaserin and Q-Nexa Before FDA